My Schwab shares are correct now. The count reflects the reverse split. I believe we are good to go, folks. And I think it is time to officially retire all the discussions about whether our shares in brokerage accounts exist. They do. And they will be worth between $5 and $6 / share if/when the IPO executes. Which means most people will be roughly whole at the starting gate, unless you bought a lot when the price spiked briefly a few years ago.
All that matters in the short term is executing the IPO and getting the VTRO listing approved. Longer term, everything (for early investors) will rest on the two early clinical trials. If those don't go well, that will be the ballgame for early investors -- even if the company survives, we will be diluted into irrelevance in that case. As for the IPO, it seems very clear that they are out of operating cash and it has to happen soon. They keep executing small, month to month capital infusions, presumably to pay the bills until the IPO happens. They can't keep doing that forever. And the recent activity suggests to me that they are ready to just do the IPO.
So let's hope that is true. And after it happens, we can begin to look at the science again. Wouldn't that be nice?
